President Donald Trump, who has been promising big changes at FDA, said he has a "fantastic person" lined up for the role of FDA commissioner that will be named soon.
The likely candidates, as reported by Business Insider, include Jim O'Neill, Dr. Scott Gottlieb, and Dr. Joseph Gulfo.
Jim O'Neill, managing director at Mithril Capital, a libertarian who has said he's in favor of approving drugs that are safe, before they're shown to be effective.
Dr. Scott Gottlieb, a resident fellow at the American Enterprise Institute and former deputy commissioner of the FDA during George W. Bush's presidency. Gottlieb has emerged as a favorite among drug executives.
Dr. Joseph Gulfo, a former biotech executive who advocates for a color-coded approval system.
Latest from Quality Assurance & Food Safety
- USDA Indefinitely Delays Salmonella Testing Program for Raw Breaded Stuffed Chicken
- American Soybean Association Names New Industry Relations Leadership
- Babybel Transitions From Cellophane to Paper Packaging
- Ambriola Company Recalls Cheese Products Due to Listeria Risk
- Horizon Family Brands Acquires Maple Hill Creamery
- Kellanova Shares Top Five Consumer Packaged Goods Tech Trends Shaping 2026
- Stay Ahead of Supply Chain Pressure
- Brendan Niemira Named IFT Chief Science and Technology Officer
